CARDIOMYOPATHY, SECONDARY
Clinical trials for CARDIOMYOPATHY, SECONDARY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, SECONDARY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, SECONDARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial aims to repair hearts in rare neurological disease
Disease control OngoingThis early-stage trial tests a gene therapy called LX2006 in 8 people with Friedreich's ataxia who also have heart muscle disease. The therapy delivers a healthy copy of the FXN gene to heart cells using a modified virus. The main goal is to check safety over 5 years, while also …
Matched conditions: CARDIOMYOPATHY, SECONDARY
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Pacemaker study aims to predict and prevent heart weakening
Knowledge-focused OngoingThis study is observing 4,500 people who need pacemakers or similar heart devices. The goal is to create a tool that predicts who is at risk of developing a weakened heart from the device itself. By identifying high-risk patients early, doctors can choose better pacing methods to…
Matched conditions: CARDIOMYOPATHY, SECONDARY
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC